In addiation, increasing evidence confirmed that inhibition of COL1A1 could significantly suppress cancer cells proliferation, clonogenicity, and invasion, indicating that COL1A1 is a putative therapeutic target for cancer (35, 37, 38). The gene discussed is COL1A1; the disease is cancer.